Citation: Yn. Li et al., Quantification of epimeric budesonide and fluticasone propionate in human plasma by liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry, J CHROMAT B, 761(2), 2001, pp. 177-185
Authors:
Teng, XW
Foe, K
Brown, KF
Cutler, DJ
Davies, NM
Citation: Xw. Teng et al., High-performance liquid chromatographic analysis of mometasone furoate andits degradation products - Application to in vitro degradation studies, J PHARM B, 26(2), 2001, pp. 313-319
Authors:
Feddah, MR
Brown, KF
Gipps, EM
Davies, NM
Citation: Mr. Feddah et al., In-vitro characterisation of metered dose inhaler versus dry powder inhaler glucocorticoid products: Influence of inspiratory flow rates, J PHARM P S, 3(3), 2000, pp. 317-324
Authors:
Seeto, C
Namkung-Matthai, H
Jayram, S
Foe, K
Brown, KF
Hughes, JM
Mason, RS
Armour, CL
Seale, JP
Citation: C. Seeto et al., Differential potency of beclomethasone esters in-vitro on human T-lymphocyte cytokine production and osteoblast activity, J PHARM PHA, 52(4), 2000, pp. 417-423
Citation: K. Foe et al., Comparative kinetics of metabolism of beclomethasone propionate esters in human lung homogenates and plasma, J PHARM SCI, 89(9), 2000, pp. 1143-1150
Authors:
Ray, MJ
Brown, KF
Burrows, CA
O'Brien, MF
Citation: Mj. Ray et al., Economic evaluation of high-dose and low-dose aprotinin therapy during cardiopulmonary bypass, ANN THORAC, 68(3), 1999, pp. 940-945
Citation: Kj. Smith et al., Influence of flow rate on aerosol particle size distributions from pressurized and breath-actuated inhalers, J AEROSOL M, 11(4), 1998, pp. 231-245